王大英,金惠根.痰浊为冠状动脉介入治疗后再狭窄的重要病机之一[J].中国中西医结合杂志,2005,(8):750-753 |
痰浊为冠状动脉介入治疗后再狭窄的重要病机之一 |
Turbid-Phlegm Is An Important Pathogenesis of Restenosis after Percutaneous Transluminal Coronary Intervention |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 痰浊 冠状动脉介入治疗 再狭窄 |
英文关键词:turbid-phlegm percutaneous transluminal coronary intervention restenosis |
基金项目: |
|
摘要点击次数: 1217 |
全文下载次数: 1459 |
中文摘要: |
冠状动脉介入治疗后的再狭窄发生率较高,已经证实中医药治疗有防治再狭窄作用,本文从冠脉造影结果、血脂、血黏度、纤溶系统、自由基、血浆同型半胱氨酸水平、胰岛素抵抗等多方面证据说明痰浊与冠脉介入后再狭窄有直接关系,因而指出痰浊是冠状动脉介入治疗后再狭窄的重要中医病机之一。 |
英文摘要: |
The occurrence rate of restenosis after percutaneous transluminal coronary intervention (PCI) was quite high. Traditional Chinese medicine (TCM) has been proved to have the effect in preventing and curing restenosis. In this article, turbid-phlegm was proved to be directly related with restenosis after PCI in aspects of coronary arteriography, blood lipid, blood viscosity, fibrolysis system, free radicals, plasma homocysteine, insulin resistance, etc. So it is one of the important pathogenetic factors of restenosis after PCI in TCM. |
关闭 |
|
|
|